These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 28685851

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
    Brewer JD, Shanafelt TD, Call TG, Cerhan JR, Roenigk RK, Weaver AL, Otley CC.
    Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
    [Abstract] [Full Text] [Related]

  • 3. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
    Lam CJ, Curtis RE, Dores GM, Engels EA, Caporaso NE, Polliack A, Warren JL, Young HA, Levine PH, Elmi AF, Fraumeni JF, Tucker MA, Morton LM.
    J Clin Oncol; 2015 Oct 01; 33(28):3096-104. PubMed ID: 26240221
    [Abstract] [Full Text] [Related]

  • 4. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
    Amber KT, Bloom R, Nouri K.
    Am J Clin Dermatol; 2016 Feb 01; 17(1):71-7. PubMed ID: 26386881
    [Abstract] [Full Text] [Related]

  • 5. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
    Abuamsha H, Kadri AN, Hernandez AV.
    Hematol Oncol; 2019 Aug 01; 37(3):261-269. PubMed ID: 30916804
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
    Howlader N, Morton LM, Feuer EJ, Besson C, Engels EA.
    Cancer Epidemiol Biomarkers Prev; 2016 Jan 01; 25(1):174-9. PubMed ID: 26472423
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.
    Morton LM, Curtis RE, Linet MS, Bluhm EC, Tucker MA, Caporaso N, Ries LA, Fraumeni JF.
    J Clin Oncol; 2010 Nov 20; 28(33):4935-44. PubMed ID: 20940199
    [Abstract] [Full Text] [Related]

  • 12. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M, Chen BE, Jaffe ES, Travis LB.
    J Natl Cancer Inst; 2007 Feb 07; 99(3):215-22. PubMed ID: 17284716
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia.
    Kumar V, Ailawadhi S, Bojanini L, Mehta A, Biswas S, Sher T, Roy V, Vishnu P, Marin-Acevedo J, Alegria VR, Paulus A, Aulakh S, Iqbal M, Manochakian R, Tan W, Chanan-Khan A, Ailawadhi M.
    Blood Cancer J; 2019 Sep 30; 9(10):75. PubMed ID: 31570695
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
    Cerhan JR, Vachon CM, Habermann TM, Ansell SM, Witzig TE, Kurtin PJ, Janney CA, Zheng W, Potter JD, Sellers TA, Folsom AR.
    Cancer Epidemiol Biomarkers Prev; 2002 Nov 30; 11(11):1466-71. PubMed ID: 12433728
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A population level analysis of second hematological malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma survivors in the era of targeted therapies.
    Mishra R, Dima D, Kumar SA, Mian A, Taneja A, Karna R, Caimi PF, Hill BT, Dean R, Jagadeesh D.
    Hematol Oncol; 2023 Dec 30; 41(5):884-893. PubMed ID: 37309225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.